Skip to content

← All stories

Markets

Dermapharm reports 2.9% revenue growth in first half of 2026

1 source ·3 articles ·1h ago

Covered by 1 outlet

All coverage · 3 articles

Investing.com Canada ·1h ago

Dermapharm reports 2.9% revenue growth in first half of 2026

Investing.com Stock Market ·2h ago

Dermapharm reports 2.9% revenue growth in first half of 2026

Investing.com Canada ·2h ago

Cancom reports 34% EBITDA growth in first half of 2026